rs7092969
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006258.4(PRKG1):c.762+40419T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.78 in 152,158 control chromosomes in the GnomAD database, including 46,898 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.78   (  46898   hom.,  cov: 32) 
Consequence
 PRKG1
NM_006258.4 intron
NM_006258.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.109  
Publications
1 publications found 
Genes affected
 PRKG1  (HGNC:9414):  (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011] 
PRKG1 Gene-Disease associations (from GenCC):
- aortic aneurysm, familial thoracic 8Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.89  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| PRKG1 | ENST00000373980.11 | c.762+40419T>A | intron_variant | Intron 5 of 17 | 1 | NM_006258.4 | ENSP00000363092.5 | |||
| PRKG1 | ENST00000401604.8 | c.717+40419T>A | intron_variant | Intron 5 of 17 | 5 | ENSP00000384200.4 | ||||
| PRKG1 | ENST00000645324.1 | c.762+40419T>A | intron_variant | Intron 5 of 7 | ENSP00000494124.1 | |||||
| PRKG1 | ENST00000373976.9 | c.762+40419T>A | intron_variant | Intron 5 of 6 | 3 | ENSP00000363087.4 | 
Frequencies
GnomAD3 genomes  0.780  AC: 118652AN: 152040Hom.:  46852  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
118652
AN: 
152040
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.780  AC: 118755AN: 152158Hom.:  46898  Cov.: 32 AF XY:  0.776  AC XY: 57704AN XY: 74382 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
118755
AN: 
152158
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
57704
AN XY: 
74382
show subpopulations 
African (AFR) 
 AF: 
AC: 
37301
AN: 
41544
American (AMR) 
 AF: 
AC: 
10862
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2493
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3825
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
3669
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
7086
AN: 
10560
Middle Eastern (MID) 
 AF: 
AC: 
216
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
50920
AN: 
67994
Other (OTH) 
 AF: 
AC: 
1673
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1294 
 2588 
 3881 
 5175 
 6469 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 862 
 1724 
 2586 
 3448 
 4310 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2709
AN: 
3476
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.